The CONQUEST Steering Committee

A Trial Guided by Experts in the Field

To ensure that CONQUEST meets the highest standards of quality, the Scleroderma Research Foundation has assembled an expert team to guide and implement this innovative trial.

CONQUEST Steering Committee

Dinesh Khanna, MD, MSc, Co-Chair
University of Michigan School of Medicine

Toby Maher, MD, PhD, Co-Chair
Keck School of Medicine, University of Southern California

Yannick Allanore, MD, PhD
Hôpital Cochin

Shervin Assassi, MD, MS
McGovern Medical School, UTHealth Houston

Murray Baron, MD
Jewish General Hospital/McGill University

Elana Bernstein, MD
Columbia University

Vincent Cottin, MD, PhD
Louis Pradel University Hospital/Claude Bernard University

Francesco del Galdo, MD, PhD
University of Leeds

Christopher Denton, PhD
Royal Free Hospital/University College London

Jeska de Vries-Bouwstra, MD, PhD
Leiden University Medical Centre

Oliver Distler, MD
University Hospital Zurich

Tracy Frech, MD, MS
Vanderbilt Health

Jessica Gordon, MD
Hospital for Special Surgery

Kristin Highland, MD
Cleveland Clinic

Anna-Maria Hoffmann-Vold, MD, PhD
Oslo University Hospital

Laura Hummers, MD
Johns Hopkins Medicine

Yasuhiro Kondoh, MD, PhD
Tosei General Hospital

Masataka Kuwana, MD, PhD
Nippon Medical School

Marco Matucci-Cerinic, MD, PhD
Careggi University Hospital/University of Florence

Virginia Steen, MD
Georgetown University Medical Center

Luke Evnin, PhD, SRF representative non-voting member
Scleroderma Research Foundation

Greg Gordon, MD, JD, Non-voting member
Scleroderma Research Foundation, CONQUEST Study Team

More about CONQUEST.


CONQUEST is designed to rapidly advance promising treatments for scleroderma.

Learn more

Patient Impact

CONQUEST offers unique benefits for scleroderma patients.

Learn more


Read our answers to our most frequently asked questions about CONQUEST.

Learn more